|"AIDS 101 -- An Intensive," 1997|
Archive member Max Greenberg
Last Friday, the FDA approved Gilead’s Truvada as a form of HIV pre-exposure prevention, and this week they ruled favorably over the use of OraSure’s take home HIV test.
While there has been some coverage of both FDA approvals, there has not been, in our view, enough analysis, or conversation within the movement about the ruling. What do we think?
Below are a few articles about the FDA decisions, including an article from Kellee Terrell at the Body who captures the division among HIV activists over Truvada.
Over the next few weeks, Visual AIDS will be sharing reactions to the FDA’s rulings from people within our community. Let us know your reaction. Email us your images, words, and other responses at firstname.lastname@example.org